These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10474521)
1. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related]
2. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers. Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235 [TBL] [Abstract][Full Text] [Related]
3. Non-human primate (baboon) anti-gross cystic disease fluid protein-15 antibody infusion in four women with metastatic breast carcinoma. Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagensen DE Cancer Immunol Immunother; 1986; 23(2):143-7. PubMed ID: 3490912 [TBL] [Abstract][Full Text] [Related]
4. Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation. Ji R; Li Y; He C; Zhu X; He A; Lu Y Gland Surg; 2020 Dec; 9(6):2175-2186. PubMed ID: 33447568 [TBL] [Abstract][Full Text] [Related]
5. Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Tian W; Osawa M; Horiuchi H; Tomita Y Cancer Sci; 2004 Jun; 95(6):491-5. PubMed ID: 15182429 [TBL] [Abstract][Full Text] [Related]
6. Malignancy knows no boundaries. Batra S; Vaid AK; Bhargava R; Singh A BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23917363 [TBL] [Abstract][Full Text] [Related]
7. Breast Metastasis From Colorectal Carcinoma Identified by Gene Assay: Case Report and Review of Literature. Gouli S; Karki A; Allerton J Cureus; 2024 Feb; 16(2):e54952. PubMed ID: 38544632 [TBL] [Abstract][Full Text] [Related]
8. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215 [TBL] [Abstract][Full Text] [Related]
9. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987 [TBL] [Abstract][Full Text] [Related]
11. Case report: Metastatic ovarian mucinous carcinoma to the breast: diagnostic challenges and pitfalls. Laokulrath N; Lim SK; Lim HY; Gudi M; Tan PH Front Oncol; 2024; 14():1364011. PubMed ID: 38562166 [TBL] [Abstract][Full Text] [Related]
12. Advanced hormone receptor-positive/human epidermal growth factor receptor 2-positive invasive ductal carcinoma with cecal metastasis: A case report. Yang SY; Zhang J; Yang ZQ; Duan JJ; Zhang Y; Li MK; Wang L; Ye CM; Nie JY Sci Prog; 2023; 106(4):368504231201043. PubMed ID: 37828835 [TBL] [Abstract][Full Text] [Related]
13. Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics. Dundr P; Singh N; Nožičková B; Němejcová K; Bártů M; Stružinská I Diagn Pathol; 2021 Mar; 16(1):20. PubMed ID: 33706757 [TBL] [Abstract][Full Text] [Related]
14. Ovarian metastasis from breast cancer: a comprehensive review. Tian W; Zhou Y; Wu M; Yao Y; Deng Y Clin Transl Oncol; 2019 Jul; 21(7):819-827. PubMed ID: 30560347 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of breast metastases from non-breast solid tumors in 22 patients from a southern Chinese population. Sun P; Chen J; Lu J; Luo R; Li M; He J Oncol Lett; 2018 Mar; 15(3):3685-3693. PubMed ID: 29467888 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X. Haraldsson S; Klarskov L; Nilbert M; Bernstein I; Bonde J; Holck S BMC Clin Pathol; 2017; 17():11. PubMed ID: 28824332 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Kubeček O; Laco J; Špaček J; Petera J; Kopecký J; Kubečková A; Filip S Clin Exp Metastasis; 2017 Jun; 34(5):295-307. PubMed ID: 28730323 [TBL] [Abstract][Full Text] [Related]
18. Metastasis of ovarian cancer to the breast: A report of two cases and a review of the literature. Tempfer CB; El Fizazi N; Ergonenc H; Solass W Oncol Lett; 2016 Jun; 11(6):4008-4012. PubMed ID: 27313731 [TBL] [Abstract][Full Text] [Related]
19. Isolated splenic metastasis of ovaric cancer. Case report and literature review. Resta G; Vedana L; Marino S; Scagliarini L; Bandi M; Anania G G Chir; 2014; 35(7-8):181-4. PubMed ID: 25174293 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care. Hainsworth JD; Greco FA Virchows Arch; 2014 Apr; 464(4):393-402. PubMed ID: 24487792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]